Sanofi (SNY)
(Real Time Quote from BATS)
$57.48 USD
-0.15 (-0.26%)
Updated Sep 23, 2024 01:28 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Cash flow Statements
Fiscal Year End for Sanofi falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 5,844.42 | 8,819.69 | 7,362.43 | 14,066.28 | 3,142.72 |
Depreciation/Amortization & Depletion | 5,186.38 | 3,603.31 | 3,964.57 | 4,208.23 | 8,346.24 |
Net Change from Assets/Liabilities | 826.88 | -449.89 | 1,599.55 | -1,183.42 | -469.28 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -755.45 | -882.92 | -477.97 | -8,582.10 | -2,346.40 |
Net Cash From Operating Activities | 11,102.23 | 11,090.19 | 12,448.58 | 8,508.99 | 8,673.28 |
Property & Equipment | -2,174.34 | -751.22 | -1,567.61 | -1,366.19 | -663.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 11,845.65 | 0.00 |
Investments | -4,288.07 | -1,418.15 | -7,066.66 | -6,380.89 | -694.40 |
Other Investing Activities | -247.85 | -16.86 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -6,710.26 | -2,186.22 | -8,634.26 | 4,098.57 | -1,357.44 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -430.76 | -325.56 | -231.89 | -707.08 | 171.36 |
Issuance (Repayment) of Debt | -3,935.24 | -1,231.66 | -2,651.33 | -2,208.07 | -78.40 |
Increase (Decrease) Short-Term Debt | 541.15 | -80.07 | -666.09 | 54.83 | -471.52 |
Payment of Dividends & Other Distributions | -4,886.58 | -4,495.71 | -4,798.65 | -4,547.50 | -4,309.76 |
Other Financing Activities | -3.25 | -104.31 | -56.79 | -50.26 | -7.84 |
Net Cash from Financing Activities | -8,714.68 | -6,133.01 | -8,347.95 | -7,407.82 | -4,696.16 |
Effect of Exchange Rate Changes | -34.63 | 8.43 | 17.75 | -73.11 | 182.56 |
Net Change In Cash & Equivalents | -4,357.34 | 2,779.40 | -4,515.89 | 5,126.64 | 2,802.24 |
Cash at Beginning of Period | 13,784.17 | 10,639.25 | 16,462.84 | 10,768.46 | 7,756.00 |
Cash at End of Period | 9,426.83 | 13,418.65 | 11,946.94 | 15,895.10 | 10,558.24 |
Diluted Net EPS | 2.33 | 3.51 | 2.93 | 5.58 | 1.25 |
Fiscal Year End for Sanofi falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2,418.72 | 0.00 | 5,844.42 | 0.00 | 3,740.07 |
Depreciation/Amortization & Depletion | 1,556.12 | 0.00 | 5,186.38 | 0.00 | 2,004.16 |
Net Change from Assets/Liabilities | -2,844.09 | 0.00 | 826.88 | 0.00 | -1,673.76 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 401.68 | 0.00 | -755.45 | 0.00 | -185.37 |
Net Cash From Operating Activities | 1,532.43 | 0.00 | 11,102.23 | 0.00 | 3,885.10 |
Property & Equipment | -1,377.36 | 0.00 | -2,174.34 | 0.00 | -383.82 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -2,253.95 | 0.00 | -4,288.07 | 0.00 | -2,732.54 |
Other Investing Activities | -44.15 | 0.00 | -247.85 | 0.00 | -234.44 |
Net Cash from Investing Activities | -3,675.46 | 0.00 | -6,710.26 | 0.00 | -3,350.80 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -302.61 | 0.00 | -430.76 | 0.00 | -362.01 |
Issuance (Repayment) of Debt | -685.99 | 0.00 | -3,935.24 | 0.00 | -2,922.27 |
Increase (Decrease) Short-Term Debt | 6,183.56 | 0.00 | 541.15 | 0.00 | 2,512.28 |
Payment of Dividends & Other Distributions | -5,099.12 | 0.00 | -4,886.58 | 0.00 | -4,910.07 |
Other Financing Activities | 0.00 | 0.00 | -3.25 | 0.00 | -3.27 |
Net Cash from Financing Activities | 95.84 | 0.00 | -8,714.68 | 0.00 | -5,685.35 |
Effect of Exchange Rate Changes | -15.08 | 0.00 | -34.63 | 0.00 | -20.72 |
Net Change In Cash & Equivalents | -2,062.26 | 0.00 | -4,357.34 | 0.00 | -5,171.77 |
Cash at Beginning of Period | 9,379.80 | 0.00 | 13,784.17 | 0.00 | 13,887.33 |
Cash at End of Period | 7,317.54 | 0.00 | 9,426.83 | 0.00 | 8,715.57 |
Diluted Net EPS | 0.48 | 0.49 | -0.25 | 1.10 | 0.63 |